Cefixime

CAS 79350-37-1 12 current records 6 historicalSmall Molecule

Who holds supplier records for Cefixime? 12 organisations hold a current record for Cefixime: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 8 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (7), China (2), Germany (1) and South Korea (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Cefixime: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cefixime

Reading the evidence

  • 12 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    7 of the 11 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Cefixime expires 14 Dec 2028. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (12)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Cefixime. Country is the organisation's recorded country, not necessarily the manufacturing site.

India7China2Germany1South Korea1Country not recorded for 1
  • APITORIA PHARMA PRIVATE LTD
    Active DMF 26369 · latest filing Sept 2012
    IndiaCEP Company GMP cert on record
  • COVALENT LABORATORIES PRIVATE LTD
    Active DMF 27121 · latest filing Apr 2013
    IndiaCEP
  • Orchid Pharma Limited
    Active DMF 19960 · latest filing Nov 2006
    IndiaCEP Company GMP cert on record
  • PURE AND CURE HEALTHCARE PRIVATE LTD
    Active DMF 23474 · latest filing Jan 2010
    IndiaCEP
  • Qilu Antibiotics Pharmaceutical Co., Ltd.
    Active DMF 36694 · latest filing Jul 2022
    ChinaCEP Company GMP cert on record
  • Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd.
    Active DMF 41651 · latest filing Mar 2025
    ChinaCEP
  • Ceph Lifesciences Private Limited
    Active DMF 19307 · latest filing Mar 2006
    India
  • DRUG MANUFACTURING COMPANY
    Active DMF 44299 · latest filing Jun 2026
  • Lupin Limited
    Active DMF 15996 · latest filing May 2002
    India Company GMP cert on record
  • Sandoz GmbH
    Active DMF 27527 · latest filing Sept 2013
    GermanyCEP Company GMP cert on record
  • UNIMARK REMEDIES LTD
    Active DMF 26047 · latest filing Jun 2012
    India
  • HANMI FINE CHEMICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    South KoreaCEP
Need Cefixime sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (8)

Certificates of Suitability on the EDQM register for Cefixime, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 22 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG APELOA TOSPO PHARMACEUTICAL CO., LTD. JinhuaCN
CEP 2019-162 - Rev 02
Cefixime trihydrate
Sept 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2025-538 - Rev 00
Cefixime trihydrate, Process-III
Jun 2026—
QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. JinanCN
CEP 2021-361 - Rev 01
Cefixime trihydrate, Process 2
Jun 2025Inspected Jun 2026
Austria
PURE AND CURE HEALTHCARE PRIVATE LIMITED PunjabIN
CEP 2009-005 - Rev 02
Cefixime trihydrate
Jan 2025—
ORCHID PHARMA LIMITED AlathurIN
CEP 2002-125 - Rev 03
Cefixime trihydrate
Sept 2024Inspected Oct 2024
Poland
COVALENT LABORATORIES PRIVATE LIMITED HyderabadIN
CEP 2023-014 - Rev 00
Cefixime trihydrate
Jul 2024—
HANMI FINE CHEMICAL CO., LTD. Siheung-siKR
R1-CEP 2002-155 - Rev 06
Cefixime trihydrate
Jul 2019—
SANDOZ GMBH KundlAT
R1-CEP 2009-347 - Rev 02
Cefixime trihydrate
Oct 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Cefixime are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • Kyongbo Pharmaceutical Co., Ltd.
    South · Inactive DMF 27033 · filed Apr 2013
  • China · Inactive DMF 25390 · filed Sept 2011
  • ORCHID CHEMICALS AND PHARMACEUTICALS LTD
    Inactive DMF 17655 · filed Sept 2004
  • India · Inactive DMF 16313 · filed Dec 2002
  • LEDERLE LABORATORIES
    Inactive DMF 13687 · filed Sept 1998
  • Japan · Inactive DMF 9478 · filed Dec 1991

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (15 listed products contain Cefixime). The latest listed patent expires 14 Dec 2028. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Cefixime is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1541).

Chemical identity

IUPAC name
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
Canonical SMILES
C=CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)/C(=N\OCC(=O)O)/C3=CSC(=N3)N)SC1)C(=O)O
InChIKey
OKBVVJOGVLARMR-QSWIMTSFSA-N
Synonyms
Anhydrous cefixime, Cefixima, Cefixime, Cefixime anhydrous, Cefixime hydrate, Cefixime trihydrate, Cefspan, Cephoral, Citropen, CL 284,635, CL-284635, FK 027

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cephalosporin Antibacterial
Chemical structure
Cephalosporins

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Cefixime?

12 organisations hold an active US FDA Type II Drug Master File or a CEP for Cefixime: APITORIA PHARMA PRIVATE LTD (India), COVALENT LABORATORIES PRIVATE LTD (India), Orchid Pharma Limited (India), PURE AND CURE HEALTHCARE PRIVATE LTD (India), Qilu Antibiotics Pharmaceutical Co., Ltd. (China), Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd. (China), Ceph Lifesciences Private Limited (India) and DRUG MANUFACTURING COMPANY, and 4 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Cefixime Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 26369), COVALENT LABORATORIES PRIVATE LTD (DMF 27121), Orchid Pharma Limited (DMF 19960), PURE AND CURE HEALTHCARE PRIVATE LTD (DMF 23474), Qilu Antibiotics Pharmaceutical Co., Ltd. (DMF 36694), Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd. (DMF 41651), Ceph Lifesciences Private Limited (DMF 19307) and DRUG MANUFACTURING COMPANY (DMF 44299) and 3 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Cefixime records mean?

6 organisations have only inactive Type II DMFs for Cefixime. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Cefixime have a European Certificate of Suitability?

Yes. 8 organisations hold a valid CEP for Cefixime on the EDQM register, including ZHEJIANG APELOA TOSPO PHARMACEUTICAL CO., LTD. Jinhua (CN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. Jinan (CN), PURE AND CURE HEALTHCARE PRIVATE LIMITED Punjab (IN), ORCHID PHARMA LIMITED Alathur (IN) and COVALENT LABORATORIES PRIVATE LIMITED Hyderabad (IN) and 2 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Cefixime?

Yes. The latest patent listed for an approved US product containing Cefixime expires 14 Dec 2028, across 15 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Cefixime supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Cefixime?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.